23
Jul
2019

CRISPR Boosts Animal Models, Making Preclinical Research More Efficient

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

One-and-Done Gene Editing: A Feature or Flaw?
COVID-19 Drives New Push for CRISPR-Based Home Diagnostics
Mood Disorder R&D, Lacking Innovation, Turns to Psychedelics
Antibiotic Resistance Looms Large in Pandemic; CRISPR Phages Show Promise